US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge COVID vaccine to up to three billion doses in 2022.
US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge COVID vaccine to up to three billion doses in 2022.